About
Biologics, Antibodies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyArgentina
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
1,391
By Phase
PHASE3: 1PHASE2: 1PHASE2/PHASE3: 2PHASE1: 1
By Status
COMPLETED: 4RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06389474Lead Sponsor
Efficacy of INM004 in Children With STEC-HUS
PHASE3Recruiting
220 participants
Started: Oct 5, 2024 · Completed: Sep 28, 2025
NCT05569746Lead Sponsor
A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS
PHASE2Completed
57 participants
Started: Oct 6, 2022 · Completed: Jul 14, 2023
NCT04954235Lead Sponsor
Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study
N/ACompleted
847 participants
Started: May 22, 2021 · Completed: Sep 9, 2021
NCT04494984Lead Sponsor
A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.
PHASE2/PHASE3Completed
242 participants
Started: Jul 27, 2020 · Completed: Dec 30, 2020
NCT04132375Lead Sponsor
Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUS
PHASE2/PHASE3Terminated
11 participants
Started: Jul 17, 2019 · Completed: Jul 19, 2022
Locations (1)
Headquarters
Buenos Aires, Argentina
Map
Loading map...